| Jason E. Marker, M.d., P.c. | |
|
66642 Srtate Road 331 Wyatt IN 46595 | |
| (574) 633-4511 | |
| (574) 633-0281 |
| Full Name | Jason E. Marker, M.d., P.c. |
|---|---|
| Speciality | Family Medicine |
| Location | 66642 Srtate Road 331, Wyatt, Indiana |
| Authorized Official Name and Position | Jason Eric Marker (PHYSICIAN/OWNER) |
| Authorized Official Contact | 5746334511 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Jason E. Marker, M.d., P.c. 66642 Srtate Road 331 P.o. Box 90 Wyatt IN 46595 Ph: (574) 633-4511 | Jason E. Marker, M.d., P.c. 66642 Srtate Road 331 Wyatt IN 46595 Ph: (574) 633-4511 |
| NPI Number | 1225333156 |
|---|---|
| Provider Enumeration Date | 01/25/2011 |
| Last Update Date | 01/25/2011 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225333156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01050905 (Indiana) | Primary |
News Archive
The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month.
The discovery was published in the new iScience journal for interdisciplinary research by Cell Press. The newly discovered regulatory proteins differ significantly from the regulators in mouse immune cells which have been reported earlier. Some of the proteins, such as SATB1 regulating the transcription of several genes, function in the opposite way in human compared to mouse.
Al Jazeera's "101 East" reports on how, "as China faces social dilemmas such as a widening gender imbalance, it is considering loosening its so-called one-child policy."
The Center for Science in the Public Interest has sued the German drug company Bayer for falsely claiming that the selenium in Men's One A Day multivitamins might reduce the risk of prostate cancer. The lawsuit is filed in the Superior Court of California in San Francisco.
A medicine is being developed at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) which controls the concentration of oxygen radicals in immune cells, and could revolutionise treatment of inflammatory diseases or even cancer.
› Verified 5 days ago